Who You Gonna Call For US Oral Contraceptive Switch? Former FDA Official Heads Perrigo Americas

Jim Dillard, chief scientific officer for Perrigo since 2019, moves to head the North American business with research and development experience as well as a regulatory background from his work at the FDA.

• Source: Shutterstock

Perrigo Company PLC hands the reins to its North America business to a former US Food and Drug Administration official soon after it made a priority of asking the agency to approve an oral contraceptive OTC switch.

Jim Dillard, chief scientific officer for the Dublin-based private label/store brand OTC giant since 2019, replaces Rich Sorota as president of the unit Perrigo calls Consumer Self-Care Americas, according to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

More from HBW Insight